Rimas V. Lukas

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

Junfei Zhao, Andrew Chen, Robyn D. Gartrell et al. · Nature Medicine · 2019 · 956 citations

Medicine, Immunology, Oncology +14

A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma

Priya Kumthekar, Caroline H. Ko, Tatjana Paunesku et al. · Science Translational Medicine · 2021 · 318 citations · Full text

Medicine, Molecular Biology, Oncology +17

Regulatable interleukin-12 gene therapy in patients with recurrent high-grade glioma: Results of a phase 1 trial

E. Antonio Chiocca, Rimas V. Lukas, Isaac H. Solomon et al. · Science Translational Medicine · 2019 · 266 citations · Full text

Medicine, Oncology, Pharmacology +17

Atezolizumab in patients with advanced non-small cell lung cancer and history of asymptomatic, treated brain metastases: Exploratory analyses of the phase III OAK study

Shirish M. Gadgeel, Rimas V. Lukas, Jerome H. Goldschmidt et al. · Lung Cancer · 2018 · 172 citations

Medicine, Oncology, Pharmacotherapy +15

Clinical activity and safety of atezolizumab in patients with recurrent glioblastoma

Rimas V. Lukas, Jordi Rodón, Kevin Becker et al. · Journal of Neuro-Oncology · 2018 · 149 citations

Medicine, Oncology, Pharmacology +14